Matching slides 118,471
Current window 89,461-89,490
Pages 3,950
Rows per page 30
Component: Paragraphclear collectionreset all

Component

89,461-89,490 of 118,471

filter-aware
24
LSE | Investor Day Presentation Deck | 100 slidesLSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations Beat · Market Size1 hit
30
Uses a before-after framing to justify a platform transformation.LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations Beat · Market Size1 hit
32
The slide uses a hub-and-spoke diagram to illustrate different integration modes (Desktop, Component, Data/Analytics).LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations Beat · Growth PlanLoop · Cost Of Inaction1 hit
39
LSE | Investor Day Presentation Deck | 100 slidesLSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations Beat · Growth PlanLoop · Cost Of Inaction1 hit
57
LSE | Investor Day Presentation Deck | 100 slidesLSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
58
LSE | Investor Day Presentation Deck | 100 slidesLSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
61
The slide uses a visual representation of market growth from 2020 to 2025.LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations Beat · Financials1 hit
78
LSE | Investor Day Presentation Deck | 100 slidesLSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations 1 hit
85
Slide provides a structured breakdown of business segments with associated KPIs and competitive landscape.LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations 1 hit
90
LSE | Investor Day Presentation Deck | 100 slidesLSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations 1 hit
99
The slide uses a matrix-like structure to map distribution channels to product solutions.LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations 1 hit
05
The slide uses a split-layout comparing the company's mission/context on the left with the specific product value proposition and market statistics on the right.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations Beat · Problem1 hit
08
Includes a comparison to Exact Sciences' ColoGuard as a market positioning anchor.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations Beat · Solution1 hit
13
Includes a stock market snapshot of Exact Sciences and a clinical performance comparison table.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
14
Includes a disclaimer at the bottom and a product visualization.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
19
Mainz Biomed NV | Investor Presentation Deck | 23 slidesMainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
21
Includes a disclaimer at the bottom and a citation for the 85% detection rate.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
22
Mainz Biomed NV | Investor Presentation Deck | 23 slidesMainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
23
The slide includes a specific milestone criterion for February 2022 regarding biomarker specificity.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
01
Slide 1
Features a molecular structure visualization.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
05
Uses a Venn diagram to illustrate the intersection of two critical clinical challenges.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank Beat · Solution1 hit
06
Uses a before-after-bridge framework to contrast existing therapy failure with Nuvalent's solution.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank Beat · Problem1 hit
07
Uses a visual comparison diagram to explain the mechanism of action and clinical benefit of selectivity.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank Beat · Problem1 hit
08
The chart uses a Gantt-style visualization to show progress from discovery through IND enabling phases.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
14
The slide uses a medical illustration to map specific TRK receptor inhibition (TRKB, TRKC, TRKA) to corresponding neurological and physiological side effects.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank Beat · Competition1 hit
16
Includes a table of IC50 values and a line chart showing tumor volume over time for different dosages.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
18
The chart uses a logarithmic scale to show relative selectivity ratios.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
19
The kinome tree is a standard visualization in pharmacology for kinase selectivity.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
20
The slide highlights CNS activity via brain penetration, a key component of the NVL-520 target product profile.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
29
The slide uses a color-coded heatmap to indicate potency (green for high potency, yellow for lower).Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit